The role of high-density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidation

M I Mackness, C Abbott, S Arrol, P N Durrington, M I Mackness, C Abbott, S Arrol, P N Durrington

Abstract

1. The oxidation of low-density lipoprotein (LDL) is believed to play a central role in atherogenesis. We have compared the effect of antioxidant vitamins and high-density lipoprotein (HDL) on the Cu(2+)-catalysed oxidation of LDL. 2. Antioxidant vitamin supplementation significantly reduced conjugated diene formation but did not affect the formation of lipid peroxides. 3. Conversely, HDL did not affect conjugated diene formation but inhibited the formation of lipid peroxides by up to 90%. 4. The inhibition by HDL of lipid peroxide formation in oxidized LDL was dependent on the concentration of HDL and was not due to HDL chelating Cu2+. 5. Large interindividual variations in the inhibition of lipid peroxide formation by autologous HDL were evident, which were related to the rate of lipid peroxide generation in the LDL. 6. We conclude that HDL is a powerful antioxidant or more probably inhibitor of LDL oxidation in vitro and may play an important role in vivo in preventing atherosclerosis by inhibiting LDL oxidation in the artery wall.

References

    1. J Lipid Res. 1984 Oct;25(10):1017-58
    1. Crit Rev Clin Lab Sci. 1982;18(1):31-78
    1. Metabolism. 1986 Apr;35(4):311-6
    1. Diabet Med. 1987 Sep-Oct;4(5):452-6
    1. BMJ. 1989 Feb 4;298(6669):281-4
    1. N Engl J Med. 1989 Apr 6;320(14):915-24
    1. J Clin Invest. 1989 Apr;83(4):1363-74
    1. Biokhimiia. 1989 Jan;54(1):118-23
    1. J Lipid Res. 1989 Apr;30(4):597-606
    1. J Lipid Res. 1989 Apr;30(4):627-30
    1. J Biol Chem. 1989 Sep 15;264(26):15216-23
    1. FEBS Lett. 1989 Nov 6;257(2):435-8
    1. Biochim Biophys Acta. 1990 May 22;1044(2):275-83
    1. Thromb Res. 1990 May 1;58(3):251-64
    1. Atherosclerosis. 1990 Oct;84(2-3):173-81
    1. Clin Chem. 1991 Feb;37(2):238-40
    1. Proc Natl Acad Sci U S A. 1991 Jun 15;88(12):5252-6
    1. Am J Pathol. 1992 Feb;140(2):291-300
    1. Biochem Pharmacol. 1992 Mar 3;43(5):995-1000
    1. Lancet. 1992 May 16;339(8803):1183-6
    1. Clin Chim Acta. 1991 Dec 31;204(1-3):57-68
    1. Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):6993-7
    1. Free Radic Biol Med. 1992 Oct;13(4):341-90
    1. FEBS Lett. 1991 Jul 29;286(1-2):152-4
    1. J Clin Invest. 1991 Dec;88(6):1785-92
    1. J Clin Invest. 1991 Dec;88(6):2039-46
    1. J Lipid Res. 1978 Jan;19(1):65-76
    1. Lancet. 1975 Jan 4;1(7897):16-9
    1. Am Heart J. 1992 Feb;123(2):285-90
    1. Atherosclerosis. 1979 Mar;32(3):213-29
    1. Biochem Med. 1981 Jun;25(3):373-8
    1. N Engl J Med. 1986 Feb 20;314(8):488-500

Source: PubMed

3
Iratkozz fel